British Columbia Investment Management Corp Horizon Therapeutics Public LTD CO Transaction History

British Columbia Investment Management Corp

$16 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$98.98 - $115.74 $19,697 - $23,032	199 Added 1.02%	19,771 $2.29 Million
Q2 2023 Aug 11, 2023	BUY	$96.34 - $112.38 $38,054 - $44,390	395 Added 2.06%	19,572 $2.01 Million
Q1 2023 May 12, 2023	SELL	$107.32 - $113.5 $8.89 Million - $9.4 Million	-82,811 Reduced 81.2%	19,177 $2.09 Million
Q4 2022 Feb 10, 2023	SELL	$62.39 - $113.8 $4.69 Million - $8.55 Million	-75,135 Reduced 42.42%	101,988 $11.6 Million
Q3 2022 Nov 10, 2022	SELL	$58.92 - $84.67 $200,033 - $287,454	-3,395 Reduced 1.88%	177,123 $11 Million
Q2 2022 Aug 12, 2022	SELL	$79.4 - $116.36 $662,751 - $971,256	-8,347 Reduced 4.42%	180,518 $14.4 Million
Q1 2022 May 12, 2022	BUY	$86.42 - $109.81 $1.78 Million - $2.26 Million	20,583 Added 12.23%	188,865 $19.9 Million
Q4 2021 Feb 11, 2022	SELL	$98.56 - $119.91 $176,915 - $215,238	-1,795 Reduced 1.06%	168,282 $18.1 Million
Q3 2021 Nov 12, 2021	BUY	$91.91 - $110.37 $14,521 - $17,438	158 Added 0.09%	170,077 $18.6 Million
Q2 2021 Aug 09, 2021	BUY	$86.24 - $95.92 $14.7 Million - $16.3 Million	169,919 New	169,919 $15.9 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.

Account